EUVIMEDEUVIMED entdecken
Crossref

Clinical characteristics and management outcomes of acromegaly in a Tunisian university hospital: A retrospective study

Hasni, Yosra, Sawsen Nouira, El Fekih, Hamza, Wiem Saafi, Imen Halloul, Wafa Badr, Saad, Ghada, Maaroufi, Amel

Biomedicine & Healthcare Research · 20.09.2024

DOI: 10.71599/bhr.v4i1.129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedicine & Healthcare Research, erschienen am 20.09.2024. Verfasst von Hasni und 11 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acromegaly is a rare endocrine disorder characterized by excessive growth hormone (GH) secretion, primarily caused by pituitary adenomas. If untreated, it leads to significant morbidity and increased mortality. This study investigates the clinical characteristics and treatment outcomes of acromegaly patients in a Tunisian University Hospital.

Methods

We conducted a retrospective review of medical records for patients diagnosed with acromegaly in the Endocrinology Department of a University Hospital in Central Tunisia over 20 years. Data on clinical features, imaging, comorbidities, and treatment outcomes were collected and analyzed.

Results

Among 41 patients included, the mean age at diagnosis was 37±11 years. MRI revealed macroadenomas in 93.9% of cases, with 58% displaying invasiveness. Adenomas co-secreting GH and prolactin were larger (35 mm vs. 21 mm; p=0.031) and more invasive (80% vs. 23%; p=0.02) compared to GH-only adenomas. Diabetes mellitus was the most common comorbidity (43%), and affected patients were older (42 vs. 34 years; p=0.03). Surgical treatment, primarily via the transsphenoidal route, was performed in 78% of patients. Medical therapy, including somatostatin analogs and dopamine agonists, was administered to 48%, with Lanreotide being the most frequently used agent. Multimodal therapy achieved a cure rate of 29%.

Conclusion

Despite therapeutic advances, managing acromegaly remains challenging. Early diagnosis and individualized treatment strategies are essential to improve patient outcomes.

Schlagwörter

acromegalypituitary adenomagrowth hormone excesstranssphenoidal surgerysomatostatin analogueslanreotidedopamine agonistsdiabetes mellitusmultimodal therapytreatment outcomes

Zitieren

APA

Hasni, Yosra, Nouira, S., Fekih, E., Hamza, Saafi, W., Halloul, I., Badr, W., Saad, Ghada, Maaroufi, & Amel (2024). Clinical characteristics and management outcomes of acromegaly in a Tunisian university hospital: A retrospective study. Biomedicine & Healthcare Research. https://doi.org/10.71599/bhr.v4i1.129

Vancouver

Hasni, Yosra, Nouira S, Fekih E, Hamza, Saafi W, et al. Clinical characteristics and management outcomes of acromegaly in a Tunisian university hospital: A retrospective study. Biomedicine & Healthcare Research. 2024. doi:10.71599/bhr.v4i1.129

BibTeX
@article{Hasni2024,
  author = {Hasni and Yosra and Nouira, Sawsen and Fekih, El and Hamza and Saafi, Wiem and Halloul, Imen and Badr, Wafa and Saad and Ghada and Maaroufi and Amel},
  title = {Clinical characteristics and management outcomes of acromegaly in a Tunisian university hospital: A retrospective study},
  journal = {Biomedicine & Healthcare Research},
  year = {2024},
  doi = {10.71599/bhr.v4i1.129}
}
Kostenlos starten →